With a focus on inhalation toxicology and pre-clinical testing and research for some of the world’s most critical needs, Amplifybio provides expertly-crafted solutions to public and private sector clients. We serve these entities with years of experience creating comprehensive study design methods and have the ability to complete whole-body inhalation testing on multiple species. Our solutions are developed by inhalation toxicologists, technologists, and other experts who leverage state-of-the-art laboratories and equipment to complete specialized toxicity testing, acute inhalation research, and more.
Standard and customized support is a necessity to treat disease or sickness in the airways of the body. Inhalation pharmaceuticals are developed and instituted to solve those challenges.
Amplifybio leverages decades of expertise in inhalation toxicology studies for pharmaceutical and medication development partners, aerosol safety testing & vapor solutions, industry-leading acute to chronic exposure systems, and many other standard respiratory therapies for humans and animals. We produce an ever-expanding list of service capabilities, including:
Through our internal efforts and through a longstanding partnership with Battelle, Amplifybio has curated a number of thought leadership resources for inhalation toxicology and many other globally utilized services.